COVID-19 rapid guideline on VITT
This Guidelines summary covers vaccine-induced immune thrombocytopenia and thrombosis, a syndrome that has been reported in rare cases after COVID-19 vaccination
NHS statin intolerance pathway
A Guidelines summary covering the definition, classification, and management of statin intolerance
NICE stroke and TIA guideline
This concise summary (updated in April 2022) covers the rapid recognition of symptoms and diagnosis of stroke and transient ischaemic attack
NICE hypertension guideline
Guidance on the diagnosis and management of hypertension, with updated recommendations on blood pressure targets and antihypertensive drug treatment
BLS managing lymphoedema and DVT guideline
Covering symptoms and management of lymphoedema and DVT, including compression use in VTE
SIGN venous thromboembolism in COVID-19 guideline
A short summary of recommendations on preventing and managing COVID-19-related venous thromboembolism in the community
NHS lipid management pathway
This Guidelines summary covers key recommendations from national guidance on lipid management for the primary and secondary prevention of cardiovascular disease
NICE heart valve disease guideline
Covering investigation and management of heart valve disease in adults
NICE CVD guideline
A concise summary of NICE's evidence-based clinical guideline on lipid modification for the prevention of cardiovascular disease
ABCD position on cardiovascular impact of glucose-lowering drugs
Key recommendations from the ABCD position statement on new glucose-lowering drugs concerning their cardiovascular impact on people with diabetes
NICE atrial fibrillation guideline
A clear summary of NICE’s guideline on atrial fibrillation management
Self Care Forum venous disease fact sheet
A summary of recommendations for advising patients and the public on managing venous disease
CaReMeUK heart failure algorithm
A heart failure management algorithm modified from the NICE guideline, Chronic heart failure in adults: diagnosis and management
CaReMeUK cardiovascular risk optimisation algorithm
A guide for non-diabetes specialist physicians and primary care teams for cardiovascular risk optimisation in patients with type 2 diabetes and atherosclerotic cardiovascular disease
HEART UK Managing hyperlipidaemia and COVID-19
A summary of collated current evidence surrounding the safety of lipid-lowering medications in patients who have COVID-19
NICE guideline on acute coronary syndromes
A brief summary of NICE’s clinical guideline on the management of acute coronary syndromes, which covers rehabilitation and aims to improve survival and quality of life.
AWMSG advice on oral anticoagulation for non-valvular atrial fibrillation
Recommendations for primary care on the role of oral anticoagulant treatment in people with non-valvular atrial fibrillation.
BSR giant cell arteritis guideline
This summary outlines the general principles of identifying and treating patients with giant cell arteritis in primary care and specialist settings. It is recommended that general practitioners refer patients with suspected giant cell arteritis to a clinician with appropriate specialist expertise.
NICE stable angina guideline
A brief summary of NICE's clinical guideline on the management of stable angina. Includes care pathway algorithm, counselling, and secondary prevention.
Venous thromboembolic diseases: diagnosis, management and thrombophilia testing
This useful summary covers diagnosis and initial management, outpatient treatment for low-risk pulmonary embolism, anticoagulation treatment for suspected or confirmed deep vein thrombosis or pulmonary embolism, and information and support for people having anticoagulation treatment
NICE abdominal aortic aneurysm guideline
This Guidelines summary covers diagnosis, monitoring and reducing the risk of rupture, and emergency transfer to regional vascular services
NICE FH guideline
A summary of NICE guidance on the identification and management of familial hypercholesterolaemia, which includes diagnostic criteria and when to refer
NICE hypertension in pregnancy guideline
This summary covers the diagnosis and management of hypertension during pregnancy, labour, and birth.
SIGN cardiac arrhythmias guideline
Read the latest recommendations on the management of atrial fibrillation and ventricular arrhythmias in acute coronary syndrome, coronary heart disease, and left-ventricular dysfunction as well as arrhythmias associated with cardiac arrest and coronary artery bypass graft.
Stable peripheral arterial disease guideline
This guideline was developed by a multidisciplinary expert panel: Begg A et al with the support of a grant from Bayer plc.
Stable coronary artery disease guideline
This guideline was developed by a multidisciplinary expert panel: Fay M et al with the support of a grant from Bayer plc.
NICE chronic heart failure guideline
This summary of the NICE heart failure guideline covers management and monitoring treatment. Includes algorithms on diagnosis and therapies.
SIGN stable angina guideline
This summary includes management algorithms for patients with suspected angina, and patients with a definite diagnosis of stable angina.
SIGN CVD guideline
This summary covers estimation of cardiovascular event risk, lifestyle interventions, and pharmacological therapy.
NICE chest pain guideline
An easy-to-read guideline summary on the assessment and diagnosis of acute and stable chest pain, including management and referral for suspected ACS.
GOSH blood pressure monitoring guideline
A concise summary of Great Ormond Street Hospital guidance on monitoring blood pressure in infants, children, and young people.
NICE multimorbidity guideline
A useful summary on NICE's guideline on the assessment and management of co-morbidities, and how to assess frailty.
NICE varicose veins guideline
Summary of NICE's guideline on the diagnosis and management of varicose veins in adults aged 18 years and over.
SIGN stroke and dysphagia guideline
This summarises SIGN's guideline on the identification and management of dysphagia in stroke patients.
SIGN chronic heart failure guideline
This summary covers diagnosis, lifestyle, and pharmacological interventions, and includes a diagnostic algorithm for suspected chronic heart failure.
SIGN antithrombotics guideline
A clear SIGN guideline summary exploring antiplatelet and anticoagulant agents and indications for their use, including cardiac and cerebrovascular disease.
JBS cardiovascular disease prevention guideline
A clear summary of JBS' recommendations on the prevention of cardiovascular disease. Includes an algorithm to help with risk assessment and management.
Educational resources
Best practice treatment and management of patients with type 2 diabetes, cardiovascular disease, and heart failure
This management algorithm was developed by a multidisciplinary expert panel: Javaid et al with the support of an educational grant from AstraZeneca. Information intended for UK healthcare professionals.
Anticoagulation management for elderly patients with NVAF, CKD and other comorbidities
This promotional webinar was organised and funded by the Bristol Myers Squibb/Pfizer Alliance and is intended for UK healthcare professionals only.
Click HERE to view ELIQUIS (apixaban) prescribing information and adverse events reporting
Adverse events should be reported. Reporting forms and information can be found at: UK – www.mhra.gov.uk/yellowcard, or search for MHRA Yellow Card in the Google Play or Apple App Store Adverse events should also be reported to Bristol-Myers Squibb via medical.information@bms.com or 0800 731 1736 (UK).
432-GB-2200204 May 2022
Identify, optimise treatment, refer—treating familial hypercholesterolaemia (FH) in primary care
This eLearning module has been commissioned and funded by Amgen Ltd and developed in partnership with Guidelines.
By logging in to this page you confirm your understanding that you are about to view content intended for UK HCPs only.
The content has been developed in collaboration with, and funded by, Amgen Ltd.
SC-UKIE-AMG145-00785 | December 2021
Managing patients with non-valvular atrial fibrillation (NVAF) and diabetes—a patient case study
This promotional Learning module has been commissioned and funded by Bayer plc and developed in partnership with Guidelines.
View adverse event reporting and prescribing information for Xarelto▼(rivaroxaban)
PP-XAR-GB-2416 March 2022
Transitioning eligible patients with NVAF from warfarin to direct oral anticoagulants—a patient case study
This promotional Learning module has been commissioned and funded by Bayer plc and developed in partnership with Guidelines.
View adverse event reporting and prescribing information for Xarelto▼(rivaroxaban)
PP-XAR-GB-2415 January 2022